Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
ImmuneOnco Biopharma
company
About
ImmuneOnco is a tumor immunotherapy product developer engaged in the development and research of tumor immunotherapy products.
- 11 - 50
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $15.80M
- Industries
- Biopharma,Biotechnology,Health Care
- Founded date
- Jun 1, 2015
- Number Of Employee
- 11 - 50
- Operating Status
- Active
ImmuneOnco Biopharma, founded in June of 2015 in Zhangjiang High-Tech Park of Shanghai, China, is an early stage biopharmaceutical company dedicated to the development and commercialization of novel cancer immunotherapy products designed to reverse cancer cell-induced immune inhibition and to actively eradicate cancer cells.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$140.80M
ImmuneOnco Biopharma has raised a total of
$140.80M
in funding over 2 rounds. Their latest funding was raised on
Dec 31, 2021 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 31, 2021 | Series Unknown | $100M | 2 | — | — | Detail |
| Oct 12, 2020 | Series B | $25M | 2 |
Lilly Asia Ventures
|
— | Detail |
| Apr 11, 2018 | Series A | $15.80M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
1
3
ImmuneOnco Biopharma is funded by 3 investors.
Milestone
and Lilly Asia Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Milestone
|
— | Series Unknown |
|
Lilly Asia Ventures
|
— | Series Unknown |
|
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
